Schedule 13G ownership disclosure

Phio Pharmaceuticals Corp.

Security class unavailable · CUSIP: 71880W303

Event date: 2020-02-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
185,705
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000069
Form type
SC 13G
Filer
Phio Pharmaceuticals Corp.
CIK
CIK 1533040
Filed
Feb 11, 2020
Reporting period
Feb 11, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub